Faeth Therapeutics
FTH
10 hedge funds and large institutions have $600K invested in Faeth Therapeutics in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 10 closing their positions.
2.13% less ownership
Funds ownership: 7.67% → 5.54% (-2.1%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
21% less capital invested
Capital invested by funds: $760K → $600K (-$160K)
50% less funds holding
Funds holding: 20 → 10 (-10)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$4.13K |
| 2 |
SS
SBI Securities
Tokyo,
Japan
|
+$1.03K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$93 |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$7 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$69.9K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
-$59.4K |
| 3 |
BFM
Boothbay Fund Management
New York
|
-$42.8K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$10.2K |
| 5 |
State Street
Boston,
Massachusetts
|
-$10.2K |
FTH Hedge Fund Activity: Q2 2025 in Review
10 of the 7,614 institutional investors tracked by Wall St. Rank reported a position in Faeth Therapeutics (FTH) for Q2 2025, worth a combined $600K — down 21% from $760K a quarter earlier.
Sellers outnumbered buyers: 10 funds closed out of FTH and 0 opened new positions — a net loss of 10 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Bank of America, adding an estimated $4.13K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $69.9K sold.
- 10 institutional investors held Faeth Therapeutics (FTH) as of Q2 2025, down from 20 in Q1 2025.
- Funds reported $600K of Faeth Therapeutics stock for Q2 2025, down 21% quarter-over-quarter.
- 0 funds opened new Faeth Therapeutics positions in Q2 2025 and 10 closed out, a net change of -10 holders.
- The largest Faeth Therapeutics buyer in Q2 2025 was Bank of America, an estimated $4.13K added.
- The largest Faeth Therapeutics seller in Q2 2025 was Renaissance Technologies, an estimated $69.9K sold.
Based on aggregated 13F filings for Q2 2025.